Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
In 1985, the Virus-Serum-Toxin Act was amended to include biologics sold in intrastate.
3; Seeley et al., 1985). The problem with such allegations is that they develop a life of their own, no matter how unbelievable they are.
At least 66 people died after the accident. (Reprinted with permission from Meselson et al., 1994 © (1994) American Association for the Advancement of Science.)
In 1996, the units of the veterinary biologics program were reunited under VS and formed the Center for Veterinary Biologics.
Am., 253 (9), 122–131. [Google Scholar]Török T.J. et al. (1997) A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars.
Breithaupt H. (2000) Toxins for terrorists.
Enserink M. (2002) Did bioweapons test cause a deadly smallpox outbreak? Science, 296, 2116–2117. [PubMed] [Google Scholar]
Purver R. (2002) Chemical and Biological Terrorism: the Threat According to the Open Literature.
The FDA approves natalizumab, a monotherapy for the treatment of patients with relapsing forms of MS. FDA later approves natalizumab (2008) for the treatment of moderate-to-severe Crohn’s disease in patients who have failed or cannot tolerate available therapies.
In July 2009, the Center colocated with the National Veterinary Services Laboratories and the National Animal Disease Center as part of the newly formed National Centers for Animal Health.
Biogen and AbbVie receive FDA approval of once-monthly daclizumab for MS. It will be approved in the European Union in July 2016.
2017 and continues to serve as Biogen’s CEO and board member today.
Nusinersen, the first treatment for spinal muscular atrophy, is approved in the United States It is approved in the European Union in 2017.
© 2022 Informa UK Limited, an Informa Plc company
Rate Biologic's efforts to communicate its history to employees.
Do you work at Biologic?
Is Biologic's vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Listen Technologies | 1998 | $5.5M | 82 | 1 |
| Vaisala | 1936 | $376.7M | 1,801 | - |
| Valent U.S.A | 1988 | $500.0M | 341 | 6 |
| VPC | 1959 | $45.0M | 100 | 6 |
| Fluke | 1948 | $6.2B | 2,525 | - |
| Mettler-Toledo International | 1989 | $3.0B | 15,000 | 71 |
| International Technologies Inc. | - | $570,000 | 7 | 37 |
| NDT Systems | - | $4.5M | 18 | - |
| KYZEN | 1990 | $8.5M | 27 | - |
| Carl Zeiss Meditec, Inc. | 2000 | $1.3B | 3,531 | - |
Zippia gives an in-depth look into the details of Biologic, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Biologic. The employee data is based on information from people who have self-reported their past or current employments at Biologic. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Biologic. The data presented on this page does not represent the view of Biologic and its employees or that of Zippia.
Biologic may also be known as or be related to Bio-Logic Usa, LLC, Bio-logic Science Instruments, BioLogic Science Instruments and Biologic.